Live Breaking News & Updates on உள்ளே ஃபைசர்

Stay informed with the latest breaking news from உள்ளே ஃபைசர் on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in உள்ளே ஃபைசர் and stay connected to the pulse of your community

10 Thursday AM Reads - The Big Picture

10 Thursday AM Reads - The Big Picture
ritholtz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ritholtz.com Daily Mail and Mail on Sunday newspapers.

China , New-york , United-states , Texas , London , City-of , United-kingdom , Washington , San-francisco , California , Texans , America

12 Noteworthy Recent Book Deals

12 Noteworthy Recent Book Deals
forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.

Greece , United-states , American , Greek , Kim-johnson , Spiegel-grau , Ben-beatriz , Robert-reid-pharr , Albert-bourla , Katy-tanis , Katalina-gamarra , Octavia-butler

Pfizer Chairman-CEO Albert Bourla writes book on company's race to create COVID-19 vaccine


Pfizer Chairman-CEO Albert Bourla writes book on company's race to create COVID-19 vaccine
Firstpost
1 hour ago
The Associated Press
© Provided by Firstpost
Pfizer Chairman-CEO Albert Bourla writes book on company's race to create COVID-19 vaccine
New York: Pfizer Chairman and CEO Dr Albert Bourla can now tell the incredible story.
Bourla has a deal with Harper Business for what the publisher is calling “an exclusive, first-hand, behind-the-scenes story” of how the drugmaker managed to develop an effective vaccine against COVID-19 in a remarkably short period of time — months instead of years. Bourla’s
Moonshot: Inside Pfizer’s Nine-Month Race to Make the Impossible Possible is scheduled to come out on 9 November.

New-york , United-states , Greece , Albert-bourla , Pfizer , Johnson , Firstpost-pfizer , Pfizer-chairman , Harper-business , Inside-pfizer , Nine-month-race , Impossible-possible

Pelosi's drug pricing plan stalled by centrist Democrats


POLITICO
Get the POLITICO Pulse newsletter
Email
Sign Up
By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
05/12/2021 10:00 AM EDT
Editor’s Note: POLITICO Pulse is a free version of POLITICO Pro Health Care's morning newsletter, which is delivered to our subscribers each morning at 6 a.m. The POLITICO Pro platform combines the news you need with tools you can use to take action on the day’s biggest stories.

Italy , California , United-states , San-diego , Wisconsin , India , White-house , District-of-columbia , Americans , Henry-connelly , Albert-bourla , David-lim

Pfizer head Albert Bourla writing book about Covid vaccine


Pfizer head Albert Bourla writing book about COVID vaccine
HILLEL ITALIE, AP National Writer
May 11, 2021
FacebookTwitterEmail
This combination photo shows Pfizer CEO Dr. Albert Bourla, left, and the cover art for his book, "Moonshot: Inside Pfizer's Nine-Month Race to Make the Impossible Possible." The book is scheduled for release on Nov. 9. (Robert Duron via AP, left and HarperCollins via AP)AP
NEW YORK (AP) — Pfizer Chairman and CEO Dr. Albert Bourla can now tell the incredible story.
Bourla has a deal with Harper Business for what the publisher is calling “an exclusive, first-hand, behind-the-scenes story” of how the drugmaker managed to develop an effective vaccine against COVID-19 in a remarkably short period of time — months instead of years. Bourla's “Moonshot: Inside Pfizer’s Nine-Month Race to Make the Impossible Possible” is scheduled to come out Nov. 9.

Greece , Robert-duron , Albert-bourla , Pfizer , Harpercollins , Johnson , Inside-pfizer , Nine-month-race , Impossible-possible , Pfizer-chairman , Harper-business , கிரீஸ்

Pfizer head Albert Bourla writing book about COVID vaccine | iNFOnews | Thompson-Okanagan's News Source


Hillel Italie
This combination photo shows Pfizer CEO Dr. Albert Bourla, left, and the cover art for his book, "Moonshot: Inside Pfizer's Nine-Month Race to Make the Impossible Possible." The book is scheduled for release on Nov. 9. (Robert Duron via AP, left and HarperCollins via AP)
May 11, 2021 - 6:02 AM
NEW YORK (AP) — Pfizer Chairman and CEO Dr. Albert Bourla can now tell the incredible story.
Bourla has a deal with Harper Business for what the publisher is calling “an exclusive, first-hand, behind-the-scenes story” of how the drugmaker managed to develop an effective vaccine against COVID-19 in a remarkably short period of time — months instead of years. Bourla's “Moonshot: Inside Pfizer’s Nine-Month Race to Make the Impossible Possible” is scheduled to come out Nov. 9.

Greece , Robert-duron , Hillel-italie , Albert-bourla , Pfizer , Harpercollins , Johnson , Inside-pfizer , Nine-month-race , Impossible-possible , Pfizer-chairman , Harper-business

Le PDG de Pfizer racontera dans un livre l'impossible histoire du vaccin anti-COVID

Le PDG de Pfizer racontera dans un livre l'impossible histoire du vaccin anti-COVID
acadienouvelle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acadienouvelle.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Pfizer , Flickr , Inside-pfizer , Nine-month-race , Impossible-possible , Professor-bourla , Monday-the , ஒன்றுபட்டது-மாநிலங்களில் , அமெரிக்கன்

Johnson & Johnson's Covid Vaccine Cleared by EU Regulator


Johnson & Johnson’s Single-Shot Covid Vaccine Approved by EU
Bloomberg
3/11/2021
Suzi Ring and Nikos Chrysoloras
(Bloomberg) -- Johnson & Johnson’s coronavirus vaccine won clearance from the European Union, adding the first single-dose shot to the bloc’s arsenal as it seeks to speed up a sluggish immunization campaign.
The European Commission granted a conditional marketing authorization after the EU’s drugs regulator recommended approval for all adults earlier Thursday. It’s the fourth shot to be cleared in the region after those made by AstraZeneca Plc and the University of Oxford, Pfizer Inc. and partner BioNTech SE, and Moderna Inc.

South-africa , Paul-stoffels , Bloomberg-johnson , Sam-fazeli , University-of-oxford , European-commission , Drug-administration , Astrazeneca-plc , Pfizer , Pfizer-inc , European-union , European-medicines-agency

Australia Seeks Review as Shots Held; German Cases: Virus Update


U.S. Pushes to Reopen; Canada Clears J&J Vaccine: Virus Update
Bloomberg
3/5/2021
Bloomberg News
(Bloomberg) -- New York City Mayor Bill de Blasio said he will have an announcement next week on high schools, the last tranche of the public education system whose students are still in remote learning. Maine and Arizona will ease restrictions, and Oregon ordered a full return to classrooms.
Mayor Mike Duggan may have set up Detroit for trouble by telling the city’s residents that the Johnson & Johnson single shots aren’t as effective as double-dose versions. New Jersey Governor Phil Murphy missed early opportunities to restrain the spread of Covid-19 in nursing and veterans homes, an infectious-disease physician and others told Republican lawmakers.

Montana , United-states , Australia , Changi , Singapore-general , Singapore , United-kingdom , Hong-kong , China , California , New-mexico , Connecticut